NCT00778661View on ClinicalTrials.gov

Bioequivalence Study of Amoxicillin 400 mg/Clavulanic Acid 57 mg Chewable Tablets Under Fasting Conditions

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

October 31, 2002

Study Completion Date

December 31, 2002

Conditions

Healthy

Interventions

DRUG

amoxicillin 400mg + clovalunic acid 57.5mg tablets

Trial Locations (1)

85044

MDS Pharma Services, Phoenix

All Listed Sponsors

lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00778661 - Bioequivalence Study of Amoxicillin 400 mg/Clavulanic Acid 57 mg Chewable Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter